Suppr超能文献

自身免疫性溶血性贫血作为恶性胸腺瘤的首发表现

Autoimmune hemolytic anemia as the presenting manifestation of malignant thymoma.

作者信息

Rubinstein I, Langevitz P, Hirsch R, Berkowicz M, Lieberman Y, Shibi G

出版信息

Acta Haematol. 1985;74(1):40-2. doi: 10.1159/000206162.

Abstract

Severe autoimmune hemolytic anemia is described as the presenting manifestation of malignant thymoma. The hemoglobin level was 5.7 g/dl, the direct IgG antiglobulin test (direct Coombs' test) was strongly positive and the indirect Coombs' test was weakly positive. Prompt remission of the hemolytic process was achieved by thymectomy combined with corticosteroid therapy; the hemoglobin level rose to 12.2 g/dl and both the direct and indirect Coombs' tests became negative. To our knowledge, this is the first case to be described in which autoimmune hemolytic anemia was the presenting manifestation of malignant thymoma. Autoimmune hemolytic anemia may be considered as a manifestation associated with malignant thymoma.

摘要

严重自身免疫性溶血性贫血被描述为恶性胸腺瘤的首发表现。血红蛋白水平为5.7g/dl,直接IgG抗球蛋白试验(直接库姆斯试验)呈强阳性,间接库姆斯试验呈弱阳性。通过胸腺切除术联合皮质类固醇治疗,溶血过程迅速缓解;血红蛋白水平升至12.2g/dl,直接和间接库姆斯试验均转为阴性。据我们所知,这是首例以自身免疫性溶血性贫血为恶性胸腺瘤首发表现的病例。自身免疫性溶血性贫血可被视为与恶性胸腺瘤相关的一种表现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验